Position
Squarepoint Ops LLC in Travere Therapeutics, Inc.
Back to the book · All holders of TVTX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1.7M$38.21 → $29.71
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 319.7K | $12.2M | — | — | — | 0.0% |
| Q1 2026 | 200.1K | $5.95M | $29.71 | −$1.7M | −$4.57M | 0.0% |